PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress

YZ Hu - Current medicinal chemistry, 2010 - ingentaconnect.com
The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also known as
protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital …

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

P Wu, YZ Hu - Current Medicinal Chemistry, 2010 - orbit.dtu.dk
Abstract The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also
known as protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital …

[引用][C] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

P WU, YZ HU - Current medicinal chemistry, 2010 - pascal-francis.inist.fr
PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

PI3K/Akt/mTOR pathway inhibitors in cancer: A perspective on clinical progress

P Wu, YZ Hu - Current Medicinal Chemistry, 2010 - hero.epa.gov
Abstract The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also
known as protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital …

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.

P Wu, YZ Hu - Current Medicinal Chemistry, 2010 - europepmc.org
The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also known as
protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital …

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress

P Wu, YZ Hu - Current medicinal chemistry, 2010 - pubmed.ncbi.nlm.nih.gov
The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also known as
protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital …

[引用][C] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

P WU, YZ HU - Current medicinal chemistry, 2010 - Bentham